These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28981200)

  • 21. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.
    Larson MK; Chen H; Kahn ML; Taylor AM; Fabre JE; Mortensen RM; Conley PB; Parise LV
    Blood; 2003 Feb; 101(4):1409-15. PubMed ID: 12393417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa.
    Al-Tamimi M; Grigoriadis G; Tran H; Paul E; Servadei P; Berndt MC; Gardiner EE; Andrews RK
    Blood; 2011 Apr; 117(14):3912-20. PubMed ID: 21252089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glaucocalyxin A inhibits platelet activation and thrombus formation preferentially via GPVI signaling pathway.
    Li W; Tang X; Yi W; Li Q; Ren L; Liu X; Chu C; Ozaki Y; Zhang J; Zhu L
    PLoS One; 2013; 8(12):e85120. PubMed ID: 24386454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
    Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB
    Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets.
    Martel C; Cointe S; Maurice P; Matar S; Ghitescu M; Théroux P; Bonnefoy A
    PLoS One; 2011 Apr; 6(4):e18812. PubMed ID: 21526204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
    Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diesel exhaust particles impair platelet response to collagen and are associated with GPIbα shedding.
    Forestier M; Al-Tamimi M; Gardiner EE; Hermann C; Meyer SC; Beer JH
    Toxicol In Vitro; 2012 Sep; 26(6):930-8. PubMed ID: 22542759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
    Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
    Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets.
    Poulter NS; Pollitt AY; Owen DM; Gardiner EE; Andrews RK; Shimizu H; Ishikawa D; Bihan D; Farndale RW; Moroi M; Watson SP; Jung SM
    J Thromb Haemost; 2017 Mar; 15(3):549-564. PubMed ID: 28058806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human megakaryocytic cell line UT-7/TPO expresses functional platelet agonist signals mediated through GPVI and thromboxane receptor.
    Kawaguchi T; Hashimoto R; Yokota H
    Cell Biol Int; 2010 Sep; 34(9):943-9. PubMed ID: 20522022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI.
    Andrews RK; Gardiner EE; Asazuma N; Berlanga O; Tulasne D; Nieswandt B; Smith AI; Berndt MC; Watson SP
    J Biol Chem; 2001 Jul; 276(30):28092-7. PubMed ID: 11344165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiscale prediction of patient-specific platelet function under flow.
    Flamm MH; Colace TV; Chatterjee MS; Jing H; Zhou S; Jaeger D; Brass LF; Sinno T; Diamond SL
    Blood; 2012 Jul; 120(1):190-8. PubMed ID: 22517902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily.
    Jandrot-Perrus M; Busfield S; Lagrue AH; Xiong X; Debili N; Chickering T; Le Couedic JP; Goodearl A; Dussault B; Fraser C; Vainchenker W; Villeval JL
    Blood; 2000 Sep; 96(5):1798-807. PubMed ID: 10961879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood.
    Zhang D; Ebrahim M; Adler K; Blanchet X; Jamasbi J; Megens RTA; Uhland K; Ungerer M; Münch G; Deckmyn H; Weber C; Elia N; Lorenz R; Siess W
    Thromb Haemost; 2020 Jun; 120(6):977-993. PubMed ID: 32492725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillar type I collagens enhance platelet-dependent thrombin generation via glycoprotein VI with direct support of alpha2beta1 but not alphaIIbbeta3 integrin.
    Lecut C; Feijge MA; Cosemans JM; Jandrot-Perrus M; Heemskerk JW
    Thromb Haemost; 2005 Jul; 94(1):107-14. PubMed ID: 16113793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids control platelet activation and limit aggregate formation under flow.
    De Angelis V; Koekman AC; Weeterings C; Roest M; de Groot PG; Herczenik E; Maas C
    PLoS One; 2014; 9(9):e108282. PubMed ID: 25264625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.